Yu Sun
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yu Sun has a total of 76 co-authors. Here are the top co-authors by number of shared publications:
Nanako Tamiya
Department of Health Services Research, Institute of Medicine, University of Tsukuba, Ibaraki, Japan
9 shared publications- Jun Hamano
Department of Palliative and Supportive Care, Institute of Medicine, University of Tsukuba , Tsukuba 305-8575
7 shared publications Masao Iwagami
Health Services Research and Development Center, University of Tsukuba, Ibaraki, Japan
7 shared publicationsNobuo Sakata
Department of Health Services Research, Institute of Medicine, University of Tsukuba
7 shared publicationsSatoru Yoshie
Health Services Research and Development Center, University of Tsukuba
6 shared publicationsJun Komiyama
Department of Health Services Research, Institute of Medicine, University of Tsukuba, Ibaraki, Japan
4 shared publications
Latest Publications
- Open Access
- 31 October 2026
- Published by Springer Nature in Scientific Reports
Prior institutional contact and hospitalization risk after telemedicine visits for acute respiratory infections
- 31 October 2026
- Published by Springer Nature in Scientific Reports
Open AccessPrior institutional contact and hospitalization risk after telemedicine visits for acute respiratory infections
- 6 October 2026
- Published by Oxford University Press (OUP) in Family Practice
- Vol. 43 (6)
Excessive polypharmacy and complicated medication regimen are associated with Physicians’ perceived burden in home healthcare: a multicenter cross-sectional study
Background: Polypharmacy and complex medication regimens are common in home healthcare; however, their impact on physicians’ perceived burden remains unclear. This study examined the associations of polypharmacy and medication regimen complexity with physicians’ perceived burden in home healthcare. Methods: A cross-sectional study was conducted at seven home care support clinics and hospitals in Japan. Physicians completed a self-administered questionnaire for patients aged ≥18 years who were receiving home healthcare. Linear mixed-effects models were used to examine the association between the number of medications (categorized into three levels), medication regimen complexity index-Japanese (MRCI-J) scores (categorized into quartiles), and physicians’ perceived burden (assessed using a 0–100 mm visual analog scale), with physicians treated as a random effect. Results: Data were collected from 506 patients, of whom 503 were included in the analyses. The mean patient age was 82.4 years, and the median number of medications was six. The mean score for the physicians’ perceived burden was 33.6 mm. Excessive polypharmacy and the highest MRCI-J quartile were significantly associated with greater physician burden even after adjustment for covariates (regression coefficient = 8.20, 95% confidence interval (CI): 4.07–12.33; regression coefficient = 7.84, 95% CI: 3.61–12.07, respectively). Conclusions: In home healthcare, excessive polypharmacy and complex medication regimens were significantly associated with increased physician burden. These findings underscore the potential benefits of optimizing pharmacotherapy through interprofessional collaboration with community pharmacists to reduce physician workload. Further research is required to identify effective interventions for mitigating this burden. Clinical trial registration: UMIN000056282.
- 6 October 2026
- Published by Oxford University Press (OUP) in Family Practice
- Vol. 43 (6)
Excessive polypharmacy and complicated medication regimen are associated with Physicians’ perceived burden in home healthcare: a multicenter cross-sectional study
Background: Polypharmacy and complex medication regimens are common in home healthcare; however, their impact on physicians’ perceived burden remains unclear. This study examined the associations of polypharmacy and medication regimen complexity with physicians’ perceived burden in home healthcare. Methods: A cross-sectional study was conducted at seven home care support clinics and hospitals in Japan. Physicians completed a self-administered questionnaire for patients aged ≥18 years who were receiving home healthcare. Linear mixed-effects models were used to examine the association between the number of medications (categorized into three levels), medication regimen complexity index-Japanese (MRCI-J) scores (categorized into quartiles), and physicians’ perceived burden (assessed using a 0–100 mm visual analog scale), with physicians treated as a random effect. Results: Data were collected from 506 patients, of whom 503 were included in the analyses. The mean patient age was 82.4 years, and the median number of medications was six. The mean score for the physicians’ perceived burden was 33.6 mm. Excessive polypharmacy and the highest MRCI-J quartile were significantly associated with greater physician burden even after adjustment for covariates (regression coefficient = 8.20, 95% confidence interval (CI): 4.07–12.33; regression coefficient = 7.84, 95% CI: 3.61–12.07, respectively). Conclusions: In home healthcare, excessive polypharmacy and complex medication regimens were significantly associated with increased physician burden. These findings underscore the potential benefits of optimizing pharmacotherapy through interprofessional collaboration with community pharmacists to reduce physician workload. Further research is required to identify effective interventions for mitigating this burden. Clinical trial registration: UMIN000056282.
- Open Access
- 25 August 2026
- Published by Wiley in Journal of General and Family Medicine
- Vol. 27 (5)
Multimorbidity Among Patients Receiving Home Care in Japan: Prevalence, Levels, and Association With Emergency Home Visits
Background: Despite its clinical importance in primary care, the prevalence and levels of multimorbidity among patients receiving home‐based medical care remain poorly characterized, and its potential impact on emergency home visits is unclear. This study described the prevalence and levels of multimorbidity among patients receiving physician‐led home care in Japan and examined the association between multimorbidity level and emergency home visits. Methods: A multicenter cross‐sectional study was conducted in 2024 using physician‐completed questionnaires derived from medical records. Multimorbidity was defined as the presence of two or more chronic conditions. Based on prior literature, multimorbidity level was categorized as low (2–3 conditions), medium (4–5 conditions), or high (≥ 6 conditions). The primary outcome was the occurrence of an emergency home visit within the preceding month. Results: Among 506 included patients, 94.7% met criteria for multimorbidity, and 13.2% required an emergency home visit. In multivariable generalized linear mixed‐effects models with a logit link, higher multimorbidity levels were independently associated with increased odds of emergency home visits, with adjusted odds ratios of 2.16 (95% CI, 1.09–4.31) for the medium‐level group and 2.72 (95% CI, 1.19–6.19) for the high‐level group compared with the low‐level group. Conclusions: Multimorbidity was highly prevalent among Japanese patients receiving home care, exceeding prior domestic estimates while aligning with international reports. Higher levels of multimorbidity were associated with an increased likelihood of emergency home visits, suggesting that assessment of multimorbidity level may, if confirmed in future studies, inform risk stratification and policy planning for home‐based care services. Trial Registration: UMIN000056282
- 25 August 2026
- Published by Wiley in Journal of General and Family Medicine
- Vol. 27 (5)
Open AccessMultimorbidity Among Patients Receiving Home Care in Japan: Prevalence, Levels, and Association With Emergency Home Visits
Background: Despite its clinical importance in primary care, the prevalence and levels of multimorbidity among patients receiving home‐based medical care remain poorly characterized, and its potential impact on emergency home visits is unclear. This study described the prevalence and levels of multimorbidity among patients receiving physician‐led home care in Japan and examined the association between multimorbidity level and emergency home visits. Methods: A multicenter cross‐sectional study was conducted in 2024 using physician‐completed questionnaires derived from medical records. Multimorbidity was defined as the presence of two or more chronic conditions. Based on prior literature, multimorbidity level was categorized as low (2–3 conditions), medium (4–5 conditions), or high (≥ 6 conditions). The primary outcome was the occurrence of an emergency home visit within the preceding month. Results: Among 506 included patients, 94.7% met criteria for multimorbidity, and 13.2% required an emergency home visit. In multivariable generalized linear mixed‐effects models with a logit link, higher multimorbidity levels were independently associated with increased odds of emergency home visits, with adjusted odds ratios of 2.16 (95% CI, 1.09–4.31) for the medium‐level group and 2.72 (95% CI, 1.19–6.19) for the high‐level group compared with the low‐level group. Conclusions: Multimorbidity was highly prevalent among Japanese patients receiving home care, exceeding prior domestic estimates while aligning with international reports. Higher levels of multimorbidity were associated with an increased likelihood of emergency home visits, suggesting that assessment of multimorbidity level may, if confirmed in future studies, inform risk stratification and policy planning for home‐based care services. Trial Registration: UMIN000056282
- Open Access
- 1 January 2026
- Published by Japan Epidemiological Association in Journal of Epidemiology
- Vol. 36 (10) , JE20250543-320
Changes in Home-visit Care Utilization and Outcomes During the Coronavirus Disease 2019 Pandemic: Comparison Between Patients With and Without Cancer
Background: The coronavirus disease 2019 (COVID-19) pandemic disrupted access to healthcare for homebound older adults, particularly those with cancer. We compared changes in the initiation and outcomes of physician-led home-visit care among older Japanese patients with and without cancer during the pandemic.Methods: We conducted a retrospective observational study using national medical claims data of patients aged ≥65 years who began physician-led home visits between April 2018 and December 2020 in Japan. The proportions of all-cause death, in-home death, and at least one hospitalization within 90 days after the initiation of home visit care were compared between the pre-pandemic (April 2018 to December 2019) and pandemic periods (January 2020 to December 2020), stratified by cancer diagnosis. Differences between the cancer and non-cancer groups were estimated using linear regression models with an interaction term for cancer status and pandemic period.Results: Among 509,718 patients (251,311 with cancer), the initiation of home-visit care increased in both groups during the pandemic. All-cause and in-home death rates increased and hospitalization rates decreased in both groups, with greater changes among patients with cancer: 1.6% (95% confidence interval, 1.1 to 2.1) for all-cause death, 3.8% (95% CI, 3.4 to 4.3) for in-home death, and –2.9% (95% CI, –3.7 to –2.2) for hospitalization.Conclusions: During the COVID-19 pandemic, physician-led home-visit care expanded, and patients with cancer showed a greater shift toward home-based end-of-life care. These findings highlight the need for targeted resource allocation strategies to support home-visit physicians caring for patients with cancer during public health emergencies.
- 1 January 2026
- Published by Japan Epidemiological Association in Journal of Epidemiology
- Vol. 36 (10) , JE20250543-320
Open AccessChanges in Home-visit Care Utilization and Outcomes During the Coronavirus Disease 2019 Pandemic: Comparison Between Patients With and Without Cancer
Background: The coronavirus disease 2019 (COVID-19) pandemic disrupted access to healthcare for homebound older adults, particularly those with cancer. We compared changes in the initiation and outcomes of physician-led home-visit care among older Japanese patients with and without cancer during the pandemic.Methods: We conducted a retrospective observational study using national medical claims data of patients aged ≥65 years who began physician-led home visits between April 2018 and December 2020 in Japan. The proportions of all-cause death, in-home death, and at least one hospitalization within 90 days after the initiation of home visit care were compared between the pre-pandemic (April 2018 to December 2019) and pandemic periods (January 2020 to December 2020), stratified by cancer diagnosis. Differences between the cancer and non-cancer groups were estimated using linear regression models with an interaction term for cancer status and pandemic period.Results: Among 509,718 patients (251,311 with cancer), the initiation of home-visit care increased in both groups during the pandemic. All-cause and in-home death rates increased and hospitalization rates decreased in both groups, with greater changes among patients with cancer: 1.6% (95% confidence interval, 1.1 to 2.1) for all-cause death, 3.8% (95% CI, 3.4 to 4.3) for in-home death, and –2.9% (95% CI, –3.7 to –2.2) for hospitalization.Conclusions: During the COVID-19 pandemic, physician-led home-visit care expanded, and patients with cancer showed a greater shift toward home-based end-of-life care. These findings highlight the need for targeted resource allocation strategies to support home-visit physicians caring for patients with cancer during public health emergencies.
- Open Access
- 22 December 2025
- Published by Springer Nature in BMC Primary Care
- Vol. 27 (1)
Physician-reported outcomes associated with collaboration between home healthcare institutions and after-hours house-call services in Japan
In Japan, home healthcare is a system in which physicians regularly visit patients at home to provide medical care. Additionally, the physicians are requir
- 22 December 2025
- Published by Springer Nature in BMC Primary Care
- Vol. 27 (1)
Open AccessPhysician-reported outcomes associated with collaboration between home healthcare institutions and after-hours house-call services in Japan
In Japan, home healthcare is a system in which physicians regularly visit patients at home to provide medical care. Additionally, the physicians are requir
- Open Access
- 15 December 2025
- Published by SAGE Publications in Palliative Care and Social Practice
- Vol. 19
Trends in prescriptions and factors associated with discontinuation of potentially inappropriate medications in elderly patients with advanced cancer at the end of life: A retrospective cohort study
Background: Potentially inappropriate medications (PIMs) pose a significant burden on patients with advanced cancer approaching the end of life. However, trends in the prescription of PIMs and the factors associated with deprescribing PIMs in these patients remain unclear. Objective: To describe trends in the prescription of PIMs and explore the factors associated with the deprescribing of PIMs in patients with advanced cancer in Japan. Design: Retrospective cohort study using medical claims data. Methods: We analyzed patients aged >65 years who were diagnosed with cancer 6 months before death and died between December 2017 and August 2023 in the city of Mito, Ibaraki prefecture, Japan. Sociodemographic, clinical, and prescription data were collected at 6 months (M6), 3 months (M3), and 1 month (M1) before death. PIMs were assessed according to the OncPal Deprescribing Guidelines. Results: The mean age of 1269 patients was 80.6 years, and 62.2% were male. PIMs were prescribed to 77.0% at M6, 76.4% at M3, and 70.0% at M1 ( p < 0.001, M6 to M1). The factors associated with deprescribing at least one PIM from M6 to M1 included female sex, number of medications at M6, number of comorbidities, admission to a palliative care unit, and admission to a general ward. Conclusion: In patients with advanced cancer, PIM use decreased as they approached death. Deprescribing PIMs was more common in females, patients with polypharmacy and comorbidities, and patients admitted to hospitals, especially palliative care units.
- 15 December 2025
- Published by SAGE Publications in Palliative Care and Social Practice
- Vol. 19
Open AccessTrends in prescriptions and factors associated with discontinuation of potentially inappropriate medications in elderly patients with advanced cancer at the end of life: A retrospective cohort study
Background: Potentially inappropriate medications (PIMs) pose a significant burden on patients with advanced cancer approaching the end of life. However, trends in the prescription of PIMs and the factors associated with deprescribing PIMs in these patients remain unclear. Objective: To describe trends in the prescription of PIMs and explore the factors associated with the deprescribing of PIMs in patients with advanced cancer in Japan. Design: Retrospective cohort study using medical claims data. Methods: We analyzed patients aged >65 years who were diagnosed with cancer 6 months before death and died between December 2017 and August 2023 in the city of Mito, Ibaraki prefecture, Japan. Sociodemographic, clinical, and prescription data were collected at 6 months (M6), 3 months (M3), and 1 month (M1) before death. PIMs were assessed according to the OncPal Deprescribing Guidelines. Results: The mean age of 1269 patients was 80.6 years, and 62.2% were male. PIMs were prescribed to 77.0% at M6, 76.4% at M3, and 70.0% at M1 ( p < 0.001, M6 to M1). The factors associated with deprescribing at least one PIM from M6 to M1 included female sex, number of medications at M6, number of comorbidities, admission to a palliative care unit, and admission to a general ward. Conclusion: In patients with advanced cancer, PIM use decreased as they approached death. Deprescribing PIMs was more common in females, patients with polypharmacy and comorbidities, and patients admitted to hospitals, especially palliative care units.
- Open Access
- 17 November 2025
- Published by Wiley in Geriatrics & Gerontology International
- Vol. 25 (12) , 1799-1811
Exploring Fall‐Related Fracture Risk by Possible Fall‐Risk Increasing Drugs in Japanese Older Adults Using Municipal Linked Medical and Long‐Term Care Claim Data: A Nested Case‐Control and Case‐Crossover Study
Aim: We examined the association between the use of fall‐risk‐increasing drugs (FRIDs) and other medications, and the risk of fall‐related fractures in Japanese community‐dwelling older adults. Methods: We used linked medical and long‐term care insurance claims data from Tsukuba City, Japan (2014–2019). Two designs were applied: a nested case‐control study comparing 1957 fracture cases to 7828 matched controls for long term use, and a case‐crossover (CCO) study for short term use including 1840 fracture cases with up to 180 days of follow‐up, in which the case period (1–30 days prior to the index date) was compared with control periods (five 30‐day periods up to 180 days prior). Medication exposure included FRIDs and other medications. The outcome was non‐vertebral fractures defined by diagnostic codes, imaging, and surgical or procedural treatment. Conditional logistic regression was used to calculate odds ratios (ORs). Results: In the nested case‐control study, the adjusted ORs (fracture cases vs. controls) for use of calcium channel blockers (1.16, 95% confidence interval [CI]: 1.05–1.33) and other anti‐dementia drugs (1.62, 95% CI: 1.11–2.37) were significantly elevated. In the CCO study, the unadjusted ORs (case period vs. control periods) for antipsychotics (3.65, 95% CI: 1.78–7.49), opioids (1.53, 95% CI: 1.05–2.22), anticonvulsants (1.86, 95% CI: 1.15–2.99), and NSAIDs (1.46, 95% CI: 1.18–1.71) were significantly elevated. Conclusion: Long‐ and short‐term use of specific medications is associated with increased fracture risk in older adults. Therefore, attention should be paid to prescription of these drugs in older adults.
- 17 November 2025
- Published by Wiley in Geriatrics & Gerontology International
- Vol. 25 (12) , 1799-1811
Open AccessExploring Fall‐Related Fracture Risk by Possible Fall‐Risk Increasing Drugs in Japanese Older Adults Using Municipal Linked Medical and Long‐Term Care Claim Data: A Nested Case‐Control and Case‐Crossover Study
Aim: We examined the association between the use of fall‐risk‐increasing drugs (FRIDs) and other medications, and the risk of fall‐related fractures in Japanese community‐dwelling older adults. Methods: We used linked medical and long‐term care insurance claims data from Tsukuba City, Japan (2014–2019). Two designs were applied: a nested case‐control study comparing 1957 fracture cases to 7828 matched controls for long term use, and a case‐crossover (CCO) study for short term use including 1840 fracture cases with up to 180 days of follow‐up, in which the case period (1–30 days prior to the index date) was compared with control periods (five 30‐day periods up to 180 days prior). Medication exposure included FRIDs and other medications. The outcome was non‐vertebral fractures defined by diagnostic codes, imaging, and surgical or procedural treatment. Conditional logistic regression was used to calculate odds ratios (ORs). Results: In the nested case‐control study, the adjusted ORs (fracture cases vs. controls) for use of calcium channel blockers (1.16, 95% confidence interval [CI]: 1.05–1.33) and other anti‐dementia drugs (1.62, 95% CI: 1.11–2.37) were significantly elevated. In the CCO study, the unadjusted ORs (case period vs. control periods) for antipsychotics (3.65, 95% CI: 1.78–7.49), opioids (1.53, 95% CI: 1.05–2.22), anticonvulsants (1.86, 95% CI: 1.15–2.99), and NSAIDs (1.46, 95% CI: 1.18–1.71) were significantly elevated. Conclusion: Long‐ and short‐term use of specific medications is associated with increased fracture risk in older adults. Therefore, attention should be paid to prescription of these drugs in older adults.
- Open Access
- 4 October 2025
- Published by Wiley in Geriatrics & Gerontology International
- Vol. 25 (11) , 1546-1554
Regional Differences in Characteristics, Service Utilization, and Outcome of Patients Receiving Physician‐Led Home Visit Care in Japan: A Nationwide Study
Aim: Physician‐led home‐visit care has become essential in the super‐aged society of Japan. To develop region‐specific service systems, understanding regional differences in patient profiles is essential. This study aimed to describe regional differences in patient characteristics, service utilization, and outcomes, and to assess the associations between regional healthcare resources and patient outcomes. Methods: This retrospective study used linked data from the National Database of Health Insurance Claims and Specific Health Checkups and the Japanese Long‐term Care Database (April 2020–March 2021). Patients aged ≥ 65 years receiving regular physician‐led home visits in October 2020 were included. Analyses were conducted by prefecture and region. Associations between regional healthcare resources and patient outcomes were assessed using Spearman's correlation coefficients ( ρ ). Results: Among 337 863 patients, regional variations were observed. Western Japan had a higher prevalence of cancer, heart disease, respiratory disease, and orthopedic disorders, whereas Tohoku showed the highest rates of high care‐need levels and home nursing utilization. Hospitalization risk was highest in western Japan, whereas in‐home deaths were more frequent in eastern Japan. Hospital bed density was positively correlated with hospitalization risk ( ρ = 0.62) and negatively with 6‐month mortality risk ( ρ = −0.44). Utilization of enhanced home care support clinics/hospitals was moderately associated with higher in‐home death risks ( ρ = 0.49). Conclusions: Substantial regional differences exist in patient characteristics, service utilization, and outcomes among older adults receiving physician‐led home‐visit care. Healthcare resources were strongly associated with hospitalization and end‐of‐life care, highlighting the need for region‐specific strategies to optimize healthcare delivery and resource allocation for the super‐aged society of Japan.
- 4 October 2025
- Published by Wiley in Geriatrics & Gerontology International
- Vol. 25 (11) , 1546-1554
Open AccessRegional Differences in Characteristics, Service Utilization, and Outcome of Patients Receiving Physician‐Led Home Visit Care in Japan: A Nationwide Study
Aim: Physician‐led home‐visit care has become essential in the super‐aged society of Japan. To develop region‐specific service systems, understanding regional differences in patient profiles is essential. This study aimed to describe regional differences in patient characteristics, service utilization, and outcomes, and to assess the associations between regional healthcare resources and patient outcomes. Methods: This retrospective study used linked data from the National Database of Health Insurance Claims and Specific Health Checkups and the Japanese Long‐term Care Database (April 2020–March 2021). Patients aged ≥ 65 years receiving regular physician‐led home visits in October 2020 were included. Analyses were conducted by prefecture and region. Associations between regional healthcare resources and patient outcomes were assessed using Spearman's correlation coefficients ( ρ ). Results: Among 337 863 patients, regional variations were observed. Western Japan had a higher prevalence of cancer, heart disease, respiratory disease, and orthopedic disorders, whereas Tohoku showed the highest rates of high care‐need levels and home nursing utilization. Hospitalization risk was highest in western Japan, whereas in‐home deaths were more frequent in eastern Japan. Hospital bed density was positively correlated with hospitalization risk ( ρ = 0.62) and negatively with 6‐month mortality risk ( ρ = −0.44). Utilization of enhanced home care support clinics/hospitals was moderately associated with higher in‐home death risks ( ρ = 0.49). Conclusions: Substantial regional differences exist in patient characteristics, service utilization, and outcomes among older adults receiving physician‐led home‐visit care. Healthcare resources were strongly associated with hospitalization and end‐of‐life care, highlighting the need for region‐specific strategies to optimize healthcare delivery and resource allocation for the super‐aged society of Japan.
- Open Access
- 17 July 2025
- Published by SAGE Publications in Journal of Primary Care & Community Health
- Vol. 16
Changes in Characteristics and Outcomes of Newly Initiated Physician-Led Home Visit Care Before and During the Coronavirus Disease 2019 Pandemic: A Multicenter Retrospective Study in Japan
Introduction: The coronavirus disease 2019 (COVID-19) pandemic disrupted healthcare systems and increased the need for home healthcare. This study examined how the pandemic influenced the characteristics and outcomes of newly initiated physician-led home visit care in Japan, particularly focusing on patients with cancer. Methods: We conducted a multicenter retrospective study using medical records from 6 home care clinics and hospitals in Ibaraki Prefecture, Japan. Patients who began physician-led home visit care between April 2019 and March 2023 were included. We compared patient characteristics, care duration, and outcomes between the pre-pandemic (April 2019 to March 2020) and pandemic (April 2020 to March 2023) periods. To examine changes before and during the pandemic, we conducted logistic regression analysis using the pandemic indicator as the exposure and home death within 1, 3, and 6 months as the outcome, adjusting for patient factors. We also examined the interaction between cancer status and the pandemic period. Results: A total of 1922 patients were included. The number of patients initiating home visit care slightly increased after the onset of the COVID-19 pandemic. The proportion of patients with cancer significantly increased during the pandemic (pre-pandemic: 37.5% vs. during-pandemic: 43.0%, P = .046). Home deaths within 1 month significantly increased during the pandemic compared to the pre-pandemic period (odds ratio (OR) [95% confidence interval (CI)]: 1.87 [1.33-2.63]). However, in the model including the interaction term, the main effect of the pandemic indicator alone disappeared, while the interaction between cancer and the pandemic showed a strong association with home death (OR [95% CI]: 9.33 [5.29-16.47]). Similar results were observed for home deaths within 3 and 6 months. Conclusions: Our findings suggest that home visit clinics adapted to the increased demands for home-based end-of-life care, particularly for patients with cancer during the pandemic. These findings highlight the need for strategic support and resource planning to manage surges in home-based care during health crisis.
- 17 July 2025
- Published by SAGE Publications in Journal of Primary Care & Community Health
- Vol. 16
Open AccessChanges in Characteristics and Outcomes of Newly Initiated Physician-Led Home Visit Care Before and During the Coronavirus Disease 2019 Pandemic: A Multicenter Retrospective Study in Japan
Introduction: The coronavirus disease 2019 (COVID-19) pandemic disrupted healthcare systems and increased the need for home healthcare. This study examined how the pandemic influenced the characteristics and outcomes of newly initiated physician-led home visit care in Japan, particularly focusing on patients with cancer. Methods: We conducted a multicenter retrospective study using medical records from 6 home care clinics and hospitals in Ibaraki Prefecture, Japan. Patients who began physician-led home visit care between April 2019 and March 2023 were included. We compared patient characteristics, care duration, and outcomes between the pre-pandemic (April 2019 to March 2020) and pandemic (April 2020 to March 2023) periods. To examine changes before and during the pandemic, we conducted logistic regression analysis using the pandemic indicator as the exposure and home death within 1, 3, and 6 months as the outcome, adjusting for patient factors. We also examined the interaction between cancer status and the pandemic period. Results: A total of 1922 patients were included. The number of patients initiating home visit care slightly increased after the onset of the COVID-19 pandemic. The proportion of patients with cancer significantly increased during the pandemic (pre-pandemic: 37.5% vs. during-pandemic: 43.0%, P = .046). Home deaths within 1 month significantly increased during the pandemic compared to the pre-pandemic period (odds ratio (OR) [95% confidence interval (CI)]: 1.87 [1.33-2.63]). However, in the model including the interaction term, the main effect of the pandemic indicator alone disappeared, while the interaction between cancer and the pandemic showed a strong association with home death (OR [95% CI]: 9.33 [5.29-16.47]). Similar results were observed for home deaths within 3 and 6 months. Conclusions: Our findings suggest that home visit clinics adapted to the increased demands for home-based end-of-life care, particularly for patients with cancer during the pandemic. These findings highlight the need for strategic support and resource planning to manage surges in home-based care during health crisis.
- Open Access
- 25 February 2025
- Published by Wiley in Geriatrics & Gerontology International
- Vol. 25 (4) , 646-647
Reply to comment on “Regional disparities in home health care utilization for older adults and their associated factors at the secondary medical area level: A nationwide study in Japan”
- 25 February 2025
- Published by Wiley in Geriatrics & Gerontology International
- Vol. 25 (4) , 646-647
Open AccessReply to comment on “Regional disparities in home health care utilization for older adults and their associated factors at the secondary medical area level: A nationwide study in Japan”